In Silico Prediction of Volume of Distribution in Humans. Extensive Data Set and the Exploration of Linear and Nonlinear Methods Coupled with Molecular Interaction Fields Descriptors

We present three in silico volume of distribution at steady state (VDss) models generated on a training set comprising 1096 compounds, which goes well beyond the conventional drug space delineated by the Rule of 5 or similar approaches. We have performed a careful selection of descriptors and kept a homogeneous Molecular Interaction Field-based descriptor set and linear (Partial Least Squares, PLS) and nonlinear (Random Forest, RF) models. We have tested the models, which we deem orthogonal in nature due to different descriptors and statistical approaches, with good results. In particular we tested the RF model, via a leave-class-out approach and by using a set of 34 additional compounds not used for training. We report comparable results against in vivo scaling approaches with geometric mean-fold error at or below 2 (for a set of 60 compounds with animal data available) and discuss the predictive performance based on the ionization states of the compounds. Lastly, we report the findings using a two-tier approach (classification followed by regression) based on VDss ranges, in an attempt to improve the prediction of compounds with very high VDss. We would recommend, overall, the RF model, with 33 descriptors, as the primary choice for VDss prediction in humans.

[1]  Yoshitaka Yano,et al.  Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles. , 2004, Journal of pharmaceutical sciences.

[2]  Franco Lombardo,et al.  In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set. , 2009, Journal of medicinal chemistry.

[3]  Robert P. Sheridan,et al.  Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction , 2013, J. Chem. Inf. Model..

[4]  Franco Lombardo,et al.  Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. , 2004, Journal of medicinal chemistry.

[5]  M Paul Gleeson,et al.  In silico human and rat Vss quantitative structure-activity relationship models. , 2006, Journal of medicinal chemistry.

[6]  I. Vattulainen,et al.  Mechanism for translocation of fluoroquinolones across lipid membranes. , 2012, Biochimica et biophysica acta.

[7]  F. Lombardo,et al.  Use of the Øie-Tozer Model in Understanding Mechanisms and Determinants of Drug Distribution , 2010, Drug Metabolism and Disposition.

[8]  Keith W Ward,et al.  A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[9]  Malcolm Rowland,et al.  PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution. , 2011, Journal of pharmaceutical sciences.

[10]  Franco Lombardo,et al.  Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 1: Volume of Distribution at Steady State , 2013, Journal of clinical pharmacology.

[11]  Benjamin A. Ellingson,et al.  Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database , 2010, J. Chem. Inf. Model..

[12]  Loriano Storchi,et al.  New and Original pKa Prediction Method Using Grid Molecular Interaction Fields , 2007, J. Chem. Inf. Model..

[13]  Franco Lombardo,et al.  Clearance mechanism assignment and total clearance prediction in human based upon in silico models. , 2014, Journal of medicinal chemistry.

[14]  Vijay K. Gombar,et al.  Quantitative Structure − Activity Relationship Models of Clinical Pharmacokinetics : Clearance and Volume of Distribution , 2013 .

[15]  Leslie Z. Benet,et al.  Effects of Drug Transporters on Volume of Distribution , 2009, The AAPS Journal.

[16]  Franco Lombardo,et al.  In silico Prediction of Total Human Plasma Clearance , 2012, J. Chem. Inf. Model..

[17]  Li Di,et al.  Volume of Distribution in Drug Design. , 2015, Journal of medicinal chemistry.

[18]  Bin Chen,et al.  Comparison of Random Forest and Pipeline Pilot Naïve Bayes in Prospective QSAR Predictions , 2012, J. Chem. Inf. Model..

[19]  Franco Lombardo,et al.  Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds , 2018, Drug Metabolism and Disposition.

[20]  Franco Lombardo,et al.  Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. , 2002, Journal of medicinal chemistry.

[21]  Franco Lombardo,et al.  A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human. , 2006, Journal of medicinal chemistry.

[22]  Alexander Golbraikh,et al.  Does Rational Selection of Training and Test Sets Improve the Outcome of QSAR Modeling? , 2012, J. Chem. Inf. Model..

[23]  S. Björkman Prediction of the volume of distribution of a drug: which tissue‐plasma partition coefficients are needed? , 2002, The Journal of pharmacy and pharmacology.